Janney Montgomery Scott
XBI icon

Janney Montgomery Scott’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Janney Montgomery Scott’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.4M Buy
120,550
+30,819
+34% +$3.85M 0.04% 421
2025
Q4 		$10.9M Buy
89,731
+46,709
+109% +$5.36M 0.03% 589
2025
Q3 		$4.31M Sell
43,022
-4,698
-10% -$423K 0.01% 947
2025
Q2 		$3.96M Sell
47,720
-19,991
-30% -$1.59M 0.01% 905
2025
Q1 		$5.49M Sell
67,711
-15,640
-19% -$1.4M 0.02% 742
2024
Q4 		$7.51M Sell
83,351
-2,206
-3% -$214K 0.02% 641
2024
Q3 		$8.45M Sell
85,557
-14,603
-15% -$1.43M 0.02% 587
2024
Q2 		$9.29M Buy
100,160
+5,210
+5% +$467K 0.03% 532
2024
Q1 		$9.01M Buy
94,950
+9,536
+11% +$885K 0.03% 567
2023
Q4 		$7.63M Sell
85,414
-65,446
-43% -$4.86M 0.02% 590
2023
Q3 		$11M Sell
150,860
-2,830
-2% -$226K 0.04% 404
2023
Q2 		$12.8M Sell
153,690
-39,421
-20% -$3.3M 0.04% 391
2023
Q1 		$14.7M Sell
193,111
-15,367
-7% -$1.28M 0.06% 304
2022
Q4 		$17.3M Sell
208,478
-41,543
-17% -$3.36M 0.07% 274
2022
Q3 		$19.8M Buy
250,021
+35,790
+17% +$3.02M 0.09% 230
2022
Q2 		$15.9M Buy
214,231
+33,937
+19% +$2.55M 0.07% 254
2022
Q1 		$16.2M Sell
180,294
-1,009
-0.6% -$93.2K 0.07% 257
2021
Q4 		$20.3M Buy
181,303
+21,610
+14% +$2.61M 0.08% 231
2021
Q3 		$20.1M Buy
159,693
+18,606
+13% +$2.4M 0.09% 220
2021
Q2 		$19.1M Buy
141,087
+9,566
+7% +$1.26M 0.08% 222
2021
Q1 		$17.8M Sell
131,521
-6,209
-5% -$930K 0.09% 208
2020
Q4 		$19.4M Buy
137,730
+21,409
+18% +$2.74M 0.09% 207
2020
Q3 		$13M Sell
116,321
-17,376
-13% -$1.95M 0.07% 249
2020
Q2 		$15M Buy
133,697
+15,843
+13% +$1.56M 0.09% 221
2020
Q1 		$9.13M Sell
117,854
-10,293
-8% -$911K 0.07% 265
2019
Q4 		$12.2M Buy
128,147
+4,936
+4% +$427K 0.08% 250
2019
Q3 		$9.39M Buy
123,211
+4,677
+4% +$389K 0.07% 288
2019
Q2 		$10.4M Buy
118,534
+2,891
+2% +$247K 0.08% 261
2019
Q1 		$10.5M Buy
115,643
+6,136
+6% +$522K 0.09% 256
2018
Q4 		$7.86M Sell
109,507
-2,030
-2% -$164K 0.08% 282
2018
Q3 		$10.7M Buy
111,537
+2,759
+3% +$267K 0.09% 242
2018
Q2 		$10.4M Buy
108,778
+7,675
+8% +$705K 0.1% 230
2018
Q1 		$8.87M Sell
101,103
-2,164
-2% -$198K 0.09% 239
2017
Q4 		$8.76M Sell
103,267
-3,951
-4% -$331K 0.09% 234
2017
Q3 		$9.28M Buy
107,218
+9,161
+9% +$734K 0.11% 217
2017
Q2 		$7.57M Buy
98,057
+9,655
+11% +$685K 0.09% 241
2017
Q1 		$6.13M Buy
88,402
+56,454
+177% +$3.79M 0.08% 256
2016
Q4 		$1.89M Buy
31,948
+21,874
+217% +$1.35M 0.03% 519
2016
Q3 		$668K Buy
+10,074
New +$623K 0.01% 820

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Janney Montgomery Scott's XBI Position: Q1 2026 in Review

Janney Montgomery Scott increased its State Street SPDR S&P Biotech ETF (XBI) stake by 34% in Q1 2026, buying an estimated $3.85M and bringing the position to 120,550 shares worth $15.4M. The position accounts for 0.04% of the portfolio, ranked #421.

Janney Montgomery Scott first reported a position in XBI in Q3 2016 and has held it in 39 quarters since. The position peaked at $20.3M in Q4 2021. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

  • Janney Montgomery Scott held 120,550 shares of State Street SPDR S&P Biotech ETF worth $15.4M as of Q1 2026.
  • Janney Montgomery Scott bought 30,819 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $3.85M.
  • State Street SPDR S&P Biotech ETF made up 0.04% of Janney Montgomery Scott's portfolio in Q1 2026, its #421 holding.
  • Janney Montgomery Scott first reported a position in State Street SPDR S&P Biotech ETF in Q3 2016 and has held it in 39 quarters since.
  • Janney Montgomery Scott's State Street SPDR S&P Biotech ETF position peaked at $20.3M in Q4 2021.
  • 813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Janney Montgomery Scott's 13F filing for Q1 2026, filed 22 Apr 2026.